| Abstrakt: |
A recent study conducted at Federal University Pelotas in Brazil has found that the combination of biogenic silver nanoparticles (Bio-AgNP) and meropenem, an antibiotic, shows promising results in treating infections caused by carbapenem-resistant Acinetobacter baumannii. The researchers evaluated the antibacterial and antibiofilm activity of Bio-AgNP and meropenem against multidrug-resistant strains of A. baumannii. The combination of Bio-AgNP and meropenem demonstrated a synergistic and additive effect, reducing the minimum inhibitory concentration (MIC) of meropenem and inhibiting biofilm formation. This research suggests that the combination therapy could be a potential therapeutic option for treating infections caused by carbapenem-resistant A. baumannii. [Extracted from the article] |
